Immunic, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Immunic, Inc. (IMUX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-10.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2019-04-10
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2019-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-09-30 was 356.17K shares, a 1275.13% increase year-over-year.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2018-06-30 was 790.62K shares.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 2.82M shares, a 100.41% increase from fiscal 2017.
- Immunic, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 1.41M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2019-03-31 | 0.00 shares 10-Q · filed 2019-04-10 | 0.00 shares derived: sum of 2 quarters · filed 2019-04-10 | 356.17K shares derived: sum of 3 quarters · filed 2019-04-10 | 1.15M shares derived: sum of 4 quarters · filed 2019-04-10 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-04 | 356.17K shares derived: sum of 2 quarters · filed 2019-03-04 | 1.15M shares derived: sum of 3 quarters · filed 2019-03-04 | 2.82M shares 10-K · filed 2019-03-04 |
| 2018-09-30 | 356.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 1.15M shares derived: sum of 2 quarters · filed 2018-11-08 | 2.82M shares 10-Q · filed 2018-11-08 | 2.84M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 790.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 2.46M shares 10-Q · filed 2018-08-07 | 2.48M shares derived: sum of 3 quarters · filed 2018-08-07 | 2.51M shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 1.67M shares 10-Q · filed 2018-05-08 | 1.69M shares derived: sum of 2 quarters · filed 2018-05-08 | 1.72M shares derived: sum of 3 quarters · filed 2018-05-08 | |
| 2017-12-31 | 22.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | 48.63K shares derived: sum of 2 quarters · filed 2018-03-13 | 1.41M shares 10-K · filed 2018-03-13 | |
| 2017-09-30 | 25.90K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-25 | 1.38M shares 10-Q · filed 2017-10-25 | ||
| 2017-06-30 | 1.36M shares 10-Q · filed 2017-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B |